Firat, P. G.Dikci, S.Can, A.Tuerkoglub, E. B.2024-08-042024-08-0420230181-55121773-0597https://doi.org/10.1016/j.jfo.2022.09.006https://hdl.handle.net/11616/101011Purpose. - To evaluate changes in the medication adherence of glaucoma patients during the COVID-19 pandemic and the factors influencing medication adherence.Materials and methods. - This cross-sectional study included a total of 197 glaucoma patients who were followed for at least six months in the Glaucoma Unit of the Ophthalmology Department of Inonu University, Faculty of Medicine. Patients were given a 28-item questionnaire, including the eight-item Morisky Medication Adherence Questionnaire, to evaluate medication adherence. Demographic and clinical data were recorded. P < 0.05 was considered statistically significant.Results. - Interruption of glaucoma clinic visits during the pandemic was reported by 82 (41.6%) patients. Nonadherence was reported by 56 patients (28.4%) (95% confidence interval: 22.1-34.7). For these patients, the most common reasons for nonadherence were forgetfulness (50%), the inability to receive a prescription for the drug (10.7%) and being busy (10.7%). Factors influencing nonadherence were determined to be younger age, female gender, interruption of glaucoma clinic visits and high-income levels (P < 0.05).Conclusion. - Interruption of glaucoma clinic visits during the COVID-19 pandemic and the resulting inability to have medications prescribed resulted in patient nonadherence with medication use.& COPY; 2022 Published by Elsevier Masson SAS.eninfo:eu-repo/semantics/openAccessGlaucomaAdherenceComplianceQuestionnaireMedicationArticle46111183643565910.1016/j.jfo.2022.09.0062-s2.0-85142424002Q3WOS:001029623000001Q3